All seragon articles
-
Business
Genentech to buy breast cancer specialist Seragon
$1.7bn deal for hormone receptor-destroying drug pipeline
-
Business
J&J buys Aragon’s prostate cancer arm
Hormone cancer specialist spins out other programmes before sale